Astroglial connexin 43 is a novel therapeutic target for chronic multiple sclerosis model
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Astroglial connexin 43 is a novel therapeutic target for chronic multiple sclerosis model ; volume:14 ; number:1 ; day:13 ; month:5 ; year:2024 ; pages:1-23 ; date:12.2024
Scientific reports ; 14, Heft 1 (13.5.2024), 1-23, 12.2024
- Creator
-
Takase, Ezgi Ozdemir
Yamasaki, Ryo
Nagata, Satoshi
Watanabe, Mitsuru
Masaki, Katsuhisa
Yamaguchi, Hiroo
Kira, Jun-ichi
Takeuchi, Hideyuki
Isobe, Noriko
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-61508-2
- URN
-
urn:nbn:de:101:1-2407222115022.720069046445
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
10.03.20252025, 12:59 AM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Takase, Ezgi Ozdemir
- Yamasaki, Ryo
- Nagata, Satoshi
- Watanabe, Mitsuru
- Masaki, Katsuhisa
- Yamaguchi, Hiroo
- Kira, Jun-ichi
- Takeuchi, Hideyuki
- Isobe, Noriko
- SpringerLink (Online service)
Other Objects (12)
Connexin 43: a New Therapeutic Target Against Chronic Kidney Disease
CD146: a potential therapeutic target for systemic sclerosis
CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
Therapeutic Targets for the Treatment of Chronic Cough
RhoA: A therapeutic target for chronic myeloid leukemia
Granulocyte-Macrophage Colony-Stimulating Factor as a Therapeutic Target in Multiple Sclerosis
Retroviral Elements in Pathophysiology and as Therapeutic Targets for Amyotrophic Lateral Sclerosis
Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets
The NLRP3 inflammasome: an emerging therapeutic target for chronic pain
Autonomic cardiovascular alterations as therapeutic targets in chronic kidney disease
Bridging the gap to therapeutic strategies based on connexin/pannexin biology
Autotaxin in encephalitogenic CD4 T cells as a therapeutic target for multiple sclerosis
Connexin 43: a New Therapeutic Target Against Chronic Kidney Disease
CD146: a potential therapeutic target for systemic sclerosis
CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
Therapeutic Targets for the Treatment of Chronic Cough
RhoA: A therapeutic target for chronic myeloid leukemia
Granulocyte-Macrophage Colony-Stimulating Factor as a Therapeutic Target in Multiple Sclerosis
Retroviral Elements in Pathophysiology and as Therapeutic Targets for Amyotrophic Lateral Sclerosis
Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets
The NLRP3 inflammasome: an emerging therapeutic target for chronic pain
Autonomic cardiovascular alterations as therapeutic targets in chronic kidney disease
Bridging the gap to therapeutic strategies based on connexin/pannexin biology
Autotaxin in encephalitogenic CD4 T cells as a therapeutic target for multiple sclerosis
Connexin 43: a New Therapeutic Target Against Chronic Kidney Disease
CD146: a potential therapeutic target for systemic sclerosis
CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
Therapeutic Targets for the Treatment of Chronic Cough
RhoA: A therapeutic target for chronic myeloid leukemia
Granulocyte-Macrophage Colony-Stimulating Factor as a Therapeutic Target in Multiple Sclerosis
Retroviral Elements in Pathophysiology and as Therapeutic Targets for Amyotrophic Lateral Sclerosis
Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets
The NLRP3 inflammasome: an emerging therapeutic target for chronic pain
Autonomic cardiovascular alterations as therapeutic targets in chronic kidney disease
Bridging the gap to therapeutic strategies based on connexin/pannexin biology